1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SBDS CTRPv2 pan-cancer AAC -0.2 2e-08
mRNA FHL2 CTRPv2 pan-cancer AAC -0.19 4e-08
mRNA UBTD1 CTRPv2 pan-cancer AAC -0.19 8e-07
mRNA CTSA CTRPv2 pan-cancer AAC -0.18 3e-07
mRNA REXO2 CTRPv2 pan-cancer AAC -0.18 2e-08
mRNA AHNAK CTRPv2 pan-cancer AAC -0.18 3e-07
mRNA SERINC3 CTRPv2 pan-cancer AAC -0.18 2e-07
mRNA HTATIP2 CTRPv2 pan-cancer AAC -0.18 3e-06
mRNA RP11-212D19.4 CTRPv2 pan-cancer AAC -0.18 8e-08
mRNA ATP6V0E1 CTRPv2 pan-cancer AAC -0.18 1e-06
Download CSV